Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

Laboratory Report

Patient
Name: Roberts, Carly
DOB: 10-DEC-1969 (Age: 56)
Gender: female
Address:
2 Price meadow
LE4 Mitchellborough (United Kingdom)
ID: 9384-259853-9 (ECI)
Report
Date: 07-NOV-2024
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
St Matthews Health & Community Centre
Malabar Road 62-66
LE1 4 Leicester (United Kingdom)
Specimen
Collected: 07-NOV-2024

Hematology

Test 07-NOV-2024 Reference Range Unit
Leukocytes [#/volume] in Blood by Automated count 5.0 4.0 - 11.0 10*3/uL
Erythrocytes [#/volume] in Blood by Automated count 4.4 4.2 - 5.4 10*6/uL
Hemoglobin [Mass/volume] in Blood 14.1 12 - 16 g/dL
Hematocrit [Volume Fraction] of Blood by Automated count 49.3 H 36 - 46 %
MCV [Entitic mean volume] in Red Blood Cells by Automated count 81.7 80 - 100 fL
MCH [Entitic mass] by Automated count 27.0 27 - 33 pg
MCHC [Entitic Mass/volume] in Red Blood Cells by Automated count 34.4 32 - 36 g/dL
Erythrocyte [DistWidth] in Blood by Automated count 12.4 11.5 - 14.5 %
Platelets [#/volume] in Blood by Automated count 161.3 150 - 450 10*3/uL

Chemistry

Test 07-NOV-2024 Reference Range Unit
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma 1260.0 H 0 - 450 pg/mL
Glucose [Mass/volume] in Serum or Plasma 86.3 65 - 99 mg/dL
Urea nitrogen [Mass/volume] in Serum or Plasma 15.7 7 - 20 mg/dL
Creatinine [Mass/volume] in Serum or Plasma 0.7 0.5 - 1.1 mg/dL
Calcium [Mass/volume] in Serum or Plasma 9.7 8.6 - 10.3 mg/dL
Sodium [Moles/volume] in Serum or Plasma 139.9 135 - 145 mmol/L
Potassium [Moles/volume] in Serum or Plasma 4.7 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Serum or Plasma 107.5 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Serum or Plasma 28.1 22 - 32 mmol/L
Protein [Mass/volume] in Serum or Plasma 7.1 6.6 - 8.3 g/dL
Albumin [Mass/volume] in Serum or Plasma 4.8 3.5 - 5.2 g/dL
Bilirubin.total [Mass/volume] in Serum or Plasma 0.7 0.1 - 1.2 mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 53.8 32 - 91 U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 38.2 7 - 56 U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 11.5 10 - 40 U/L
Magnesium [Mass/volume] in Serum or Plasma 2.0 1.7 - 2.2 mg/dL
Cholesterol [Mass/volume] in Serum or Plasma 188.6 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 134.9 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 133.7 H 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 28.0 L 40 - 60 mg/dL
Hemoglobin A1c/Hemoglobin.total in Blood 5.5 4.0 - 5.6 %
Troponin I.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method 0.0 0.0 - 19.9 pg/mL
Ferritin [Mass/volume] in Serum or Plasma 136.7 13 - 150 ug/L
Iron [Mass/volume] in Serum or Plasma 62.9 50 - 170 ug/dL
Iron binding capacity [Mass/volume] in Serum or Plasma 285.8 250 - 450 ug/dL
Iron saturation [Mass Fraction] in Serum or Plasma 20.5 15 - 50 %

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows markedly elevated NT-proBNP, suggesting possible heart failure or significant cardiac strain. Hematocrit is mildly elevated, which may indicate relative hemoconcentration or dehydration. Lipid profile reveals high LDL and low HDL cholesterol, increasing cardiovascular risk. Other parameters, including renal, liver, and glucose metabolism, are within normal limits. Clinical correlation and further cardiac evaluation are recommended.